Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PURE BiosciencePURE +13.17% PS Ratio is 3.49 as of Jul. 25, 2026, which is 59% below its 10-year median of 8.49. The stock has 5 warning signs investors should review. Among 1,940 Consumer Packaged Goods companies, PURE Bioscience ranks worse than 85.98% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, PURE Bioscience's share price is $0.07673.
PURE Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 was $0.02. Hence, PURE Bioscience's PS Ratio for today is 3.49.
The historical rank and industry rank for PURE Bioscience's PS Ratio or its related term are showing as below:
PURE'
s PS Ratio Range Over the Past 10 Years
Min: 1.95 Med: 8.49 Max: 53.16
Current: 3.49
During the past 13 years, PURE Bioscience's highest PS Ratio was 53.16. The lowest was 1.95. And the median was 8.49.
PURE's PS Ratio is ranked worse than 85.98% of 1940
companies
in the Consumer Packaged Goods industry
Industry Median: 0.85
vs PURE: 3.49
PURE Bioscience Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue per Share Growth Rate of PURE Bioscience was 37.50% per year.
During the past 3 years, the average Revenue per Share Growth Rate was -1.60% per year.
During the past 5 years, the average Revenue per Share Growth Rate was -24.90% per year.
During the past 10 years, the average Revenue per Share Growth Rate was -1.70% per year.
During the past 13 years, PURE Bioscience's highest 3-Year average Revenue per Share Growth Rate was 77.70% per year. The lowest was -71.60% per year. And the median was -8.80% per year.
Back to Basics: PS Ratio
PURE Bioscience (OTCPK:PURE) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
PURE Bioscience PS Ratio Related Terms
PURE Bioscience PS Ratio Historical Data
* Premium members only.
The historical data trend for PURE Bioscience's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Household & Personal Products subindustry, PURE Bioscience's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PURE Bioscience PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, PURE Bioscience's PS Ratio distribution charts can be found below:
* The bar in red indicates where PURE Bioscience's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
PURE Bioscience's Share Price of today is $0.07673. PURE Bioscience's Revenue per Share for the trailing twelve months (TTM) ended in Apr. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
PURE Bioscience (PURE) has a PS Ratio of 3.49 as of Jul. 25, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PURE Bioscience and its competitors. This is 59% below median its historical median of 8.49. Over the past decade, PURE Bioscience's PS Ratio has ranged from 1.95 to 53.16. According to the industry distribution chart, PURE Bioscience ranks #1668 out of 1940 companies in the Consumer Packaged Goods industry, placing it in the top 86%.
Is PURE Bioscience's PS Ratio too high?
PURE Bioscience's current PS Ratio of 3.49 is 59% below median its 10-year median of 8.49. Over the past 10 years, this metric has ranged from a low of 1.95 to a high of 53.16. The Consumer Packaged Goods industry median PS Ratio is 0.85. PURE Bioscience's value of 3.49 is 310.6% above this industry median. Based on the distribution chart, PURE Bioscience ranks #1668 out of 1940 companies in the Consumer Packaged Goods industry, which is in the bottom quartile relative to peers.
How does PURE Bioscience's PS Ratio compare to DQWS and RAY?
According to the Consumer Packaged Goods industry distribution chart, PURE Bioscience ranks #1668 out of 1940 companies for PS Ratio. This places PURE Bioscience in the lower half of its industry. The industry median PS Ratio is 0.85. PURE Bioscience's value of 3.49 is 310.6% above this benchmark. Historically, PURE Bioscience's own PS Ratio has ranged from 1.95 to 53.16 over the past decade. While the company's 10-year median is 8.49 vs. the industry median of 0.85, PURE Bioscience has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Consumer Packaged Goods company?
The median PS Ratio among Consumer Packaged Goods companies is 0.85, based on 1,940 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PURE Bioscience's current PS Ratio of 3.49 is 310.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on PURE Bioscience and its competitors. For the Consumer Packaged Goods industry, the median PS Ratio is 0.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PURE Bioscience's current PS Ratio is 3.49, which is 59% below median its own 10-year median of 8.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PURE Bioscience stock overvalued right now?
Based on GuruFocus' analysis, PURE Bioscience (PURE) is currently considered Modestly Undervalued. The stock's GF Value™ is $0.10, compared to a current price of $0.08 — trading 23.3% below its estimated fair value. The current PS Ratio is 3.49, which is 59% below median its 10-year median of 8.49 and 310.6% above the Consumer Packaged Goods industry median of 0.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For PURE Bioscience (PURE), the current PS Ratio is 3.49 as of Jul. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
PURE Bioscience Inc is engaged in developing and commercializing proprietary antimicrobial products. The company's technology platform is based on patented stabilized ionic silver, and its initial products contain silver dihydrogen citrate, or SDC. It offers PURE Hard Surface as a food contact surface sanitizer and disinfectant to restaurant chains, food processors and food transportation companies and PURE Control as a direct food contact processing aid. It also manufactures and sells SDC-based products for end use, and products preserved with SDC and SDC as a raw material ingredient for manufacturing use. The company generates revenue from the sale of its antimicrobial products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PURE has been successfully added to your 
